ArticleTherapeutic advances in psychopharmacology2026

Sodium-glucose cotransporter-2 inhibitors lower risk of kidney replacement therapy and mortality in bipolar disorder with chronic kidney disease.

Balwinder Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.